India's MedPlus Health falls after deferring fund raise plans
** Shares of MedPlus Health Services MEDP.NS fall ~2% to
699 rupees
** Pharmacy retailer said its board has decided not to
proceed with a fund raise, for which it had received
shareholders' approval on Nov. 30
** Fund raise deferred as board decided to stall expansion
plans of its diagnostics division beyond Hyderabad until pilot
project turns profitable
** Avg rating of five analysts on MEDP is "strong buy;"
median PT is 980 rupees - LSEG data
** Stock down 6.8% YTD after rising 22% in 2023
(Reporting by Kashish Tandon)
((kashish.tandon@thomsonreuters.com))
Recent news on MedPlus Health Services
See all newsBrief: Medplus Health Services Keeps Food Park And Concierge Health Facility Capex In Abeyance
India's Medplus Health Services set for worst day on record as Q1 profit plunges
India's MedPlus Health first quarter profit drops as expansion costs and competition weigh
Brief: Medplus Health Services Says Optival Health Solutions Receives Suspension Order For Drug License Of Store In Karnataka
Brief: Medplus Health Services Says Unit Optival Health Solutions Receives Three Drug License Suspension Orders In Karnataka And Andhra Pradesh